Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Doug Bean who wrote (640)	3/10/1998 8:06:00 PM
From: Thure Meyer	Read Replies (1) \| Respond to of 1837

Doug, I don't think we will see a runup until we get a 10-Q and/or some news on the Premarin substitute. The generic pill market is difficult and full of competitors. Duramed, which has hit all their targets lately needs to overcome one last giant hurdle (FDA approval) and then they will take off. Lets wait and see. I don't expect a lot of action until we get some news. I don't have the cash right now, but if I did I would buy some more even at this level. Thure